Lipid-based diets effectively combat Alzheimer's disease in mouse model

February 10, 2016
Researchers have devised several lipid-based diets aimed at slowing down progression and relieving symptoms of Alzheimer's disease. Credit: Janickova et al, Bentham Science Publishers

Alzheimer´s disease (AD) is the most common disease underlying memory problems and dementia in the elderly. One of the invariable pathologies in AD is degeneration of cholinergic synapses in brain cortex and hippocampus. Despite enormous effort to find out an efficient treatment, current pharmacological interventions are limited to a few drugs that alleviate symptoms but do not slow down the underlying disease processes. These drugs include inhibitors of cholinesterases, enzymes that degrade the neurotransmitter acetylcholine, or memantine, a modulator of glutamate neurotransmission.

It is generally accepted that lifestyle and particularly dietary habits influence mental health, and prevalence and progression of AD. Numerous epidemiological studies have revealed profitable effects of dietary intake of especially fish oil on cognitive decline during aging and dementia.

Within the EU-funded project LipiDiDiet (FP7-211696, therapeutic and preventive impact of nutritional lipids on neuronal and cognitive performance in aging, Alzheimer´s disease and vascular dementia, researchers devised several lipid-based diets aimed at slowing down progression and relieving symptoms of AD. Short-term (3 weeks) feeding of young adult APPswe/PS1dE9 mice ( of AD) with experimental diets containing fish oil or stigmasterol reversed the decrease in responsiveness of hippocampal muscarinic receptors to acetylcholine compared to their non-transgenic littermates. Only based diet enriched with nutrients supporting neuroprotection (Fortasyn diet) increased in addition the density of muscarinic receptors and cholinergic synapses in the hippocampus.

These findings yield important proof-of-principle evidence that regular intake of specific dietary components may help to prevent some of the key early functional changes that take place in the Alzheimer brain. These findings support viability of the dietary approach in AD.

Explore further: How drugs can help your brain encode memories

More information: Helena Janickova et al. Lipid-Based Diets Improve Muscarinic Neurotransmission in the Hippocampus of Transgenic APPswe/PS1dE9 Mice, Current Alzheimer Research (2015). DOI: 10.2174/1567205012666151027130350

Related Stories

How drugs can help your brain encode memories

January 14, 2016
Medical researchers at the University of Bristol have uncovered a fundamental mechanism that explains the interaction between brain state and the neural triggers responsible for learning. The discoveries, made by researchers ...

Dietary interventions can improve memory performance for diseases like Alzheimer's

October 14, 2015
Dietary supplementation could play a crucial role in keeping Europe's ageing population healthy, an EU-funded study has confirmed. The LIPIDIDIET project, which was completed in March 2015, demonstrated that women susceptible ...

Fish oil supplements reduce incidence of cognitive decline, may improve memory function

July 15, 2014
Rhode Island Hospital researchers have completed a study that found regular use of fish oil supplements (FOS) was associated with a significant reduction in cognitive decline and brain atrophy in older adults. The study examined ...

Insulin-like growth factor linked to hippocampal hyperactivity in Alzheimer's disease

February 1, 2016
The mechanisms underlying the stability and plasticity of neural circuits in the hippocampus, the part of the brain responsible for spatial memory and the memory of everyday facts and events, has been a major focus of study ...

Dietary treatment shows potential in a mouse model of Alzheimer's disease

January 24, 2014
New research findings indicate that an early onset of dietary treatment may slow down the progression of Alzheimer's disease. The study was conducted on mice, and the results will be published in the February issue of Journal ...

Endothelin B receptor drug reduces memory loss, oxidative stress in Alzheimer's disease

September 7, 2015
An estimated 5.3 million people in the U.S. suffer from Alzheimer's disease (AD)—the most common form of dementia—and roughly 473,000 people will develop the disease in 2015. There are currently five medications approved ...

Recommended for you

Is the Alzheimer's gene the ring leader or the sidekick?

September 15, 2017
The notorious genetic marker of Alzheimer's disease and other forms of dementia, ApoE4, may not be a lone wolf.

Potential noninvasive test for Alzheimer's disease

September 6, 2017
In the largest and most conclusive study of its kind, researchers have analysed blood samples to create a novel and non-invasive way of helping to diagnose Alzheimer's disease and distinguishing between different types of ...

Researchers unlock the molecular origins of Alzheimer's disease

September 6, 2017
A "twist of fate" that is minuscule even on the molecular level may cause the development of Alzheimer's disease, VCU researchers have found.

Is dementia declining among older Americans?

September 5, 2017
(HealthDay)—Here's some good news for America's seniors: The rates of Alzheimer's and other forms of dementia have dropped significantly over the last decade or so, a new study shows.

Which genetic marker is the ring leader in the onset of Alzheimer's disease?

September 4, 2017
The notorious genetic marker of Alzheimer's disease and other forms of dementia, ApoE4, may not be a lone wolf.

A decline in navigational skills could predict neurodegenerative disease

August 30, 2017
Changes in how humans map their surroundings and construct and follow directions as they age have been understudied compared to effects on memory and learning. However, age-related declines in navigational ability are independent ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.